research Pantolactams as Androgen Receptor Antagonists for the Topical Suppression of Sebum Production
Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.
Search
forLearn
0 / 0 results — no results
Research
5 / 969 results 
research Letter in Reply: Alopecia Areata After SARS-CoV-2 Vaccination
A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.
research Synthesis and Biological Evaluation of Amino-Pyridines as Androgen Receptor Antagonists for Stimulating Hair Growth and Reducing Sebum Production
A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.
research Tracking Down Autoantibodies in a 31-Year-Old IT Engineer Post Pfizer COVID-19 Vaccine
A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.
research Alopecia Areata After COVID-19 Vaccines
Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.
Community Join
5 / 40 results
community Compunded Oral Minoxidil, As Efficient As Tablet Variants?
The user discusses using compounded oral minoxidil due to the ineffectiveness and inconvenience of topical minoxidil for diffuse thinning. They question the efficacy of compounded minoxidil compared to original tablet forms and express concerns about the importance of excipients and binders.
community Should I start using min if my hair loss is caused by low ferritin / iron deficiency?
A 24-year-old woman experiencing hair loss due to low ferritin and iron deficiency is advised to correct these deficiencies before considering minoxidil. Minoxidil is not recommended for temporary hair loss caused by iron deficiency.
community Prediction: Scube3 is never coming out
Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.
community Oral Minoxidil Study of 60 AGA patients
Oral minoxidil treatment increased hair density and shaft caliber in AGA patients. Side effects included hypertrichosis and lower extremity edema, with younger patients experiencing fewer side effects.
community Started oral minoxidil today
A user started taking oral minoxidil using Rogaine, despite concerns from others about its safety and proper use. They plan to update on their progress.